Members of the CAR T Vision Steering Committee outline key issues around US and EU reimbursement and discuss potential solutions
Anna Sureda, MD, PhD
Advertisement
Articles by Anna Sureda, MD, PhD
Advertisement
Latest Updated Articles
It’s Time to Reimagine Reimbursement for CAR T-Cell TherapyDecember 2nd 2025
Advertisement
Advertisement
Trending on AJMC
1
EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology
2
Paul Richardson, MD, Calls Mezigdomide “CAR T in a Pill” for Patients With R/R Multiple Myeloma
3
MRD-Guided CLL Treatment Duration: Personalization or Malpractice?
4
Type 5 Diabetes: A Long-Ignored Condition Gets Its Moment
5